Most of us know someone who is gluten or lactose intolerant but now a new food allergy appears to be spreading across the world.
Increasing numbers of people are being diagnosed as allergic to red meat after suffering reactions to “alpha-gal”, a sugar which is found in the blood of many mammals. Although alpha-gal in meat usually poses no problems for humans, people can become sensitised to the carbohydrate after being bitten by a tick.
Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.